Guardant Health, Inc.GH
What Guardant Health, Inc. does.
We are a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. We are transforming patient care by providing critical insights into what drives disease through our advanced blood and tissue tests, real-world data and AI analytics. Our tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For patients with advanced-stage cancer, we offer the Guardant360 Liquid test, formerly known as the Guardant360 LDT test, and the Guardant360 CDx test, the first comprehensive liquid biopsy test approved by the U.S. Food and Drug Administration, or the FDA, to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer, or NSCLC, colorectal cancer and breast cancer. We also offer the Guardant360 Tissue test for advanced-stage cancer and the Guardant Reveal test to detect residual and recurring disease in early-stage colorectal, breast and lung cancer patients. We have also expanded the Guardant Reveal test to include late-stage therapy response monitoring for patients with solid tumors. Our product portfolio is now powered by our Smart Platform, which utilizes methylation technology with genomic, epigenomic, and RNA-based data, to unlock multi-modal biology with proprietary chemistry, advanced algorithms and our InfinityAI learning engine.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $286.7M | $373.7M | $449.5M | $563.9M | $739.0M | $982.0M |
| Net income | -$246.3M | -$384.8M | -$654.6M | -$479.4M | -$436.4M | -$416.3M |
| Free cash flow | -$140.1M | -$284.1M | -$386.9M | -$345.5M | -$274.9M | -$233.1M |
More on GH.
- Guardant Health, Inc. summary
- Guardant Health, Inc. financial statements
- Guardant Health, Inc. key metrics
- Guardant Health, Inc. health scores and style box
- Guardant Health, Inc. earnings
- Guardant Health, Inc. dividends
- Guardant Health, Inc. valuation
- Guardant Health, Inc. ownership and insiders
- Guardant Health, Inc. peers
Figures from Guardant Health, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.